Haleon Us Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HALEON US HOLDINGS, and when can generic versions of HALEON US HOLDINGS drugs launch?
HALEON US HOLDINGS has thirty-one approved drugs.
There are ten US patents protecting HALEON US HOLDINGS drugs.
There are two hundred and three patent family members on HALEON US HOLDINGS drugs in thirty-two countries and sixteen supplementary protection certificates in eight countries.
Summary for Haleon Us Holdings
International Patents: | 203 |
US Patents: | 10 |
Tradenames: | 28 |
Ingredients: | 18 |
NDAs: | 31 |
Drugs and US Patents for Haleon Us Holdings
Expired US Patents for Haleon Us Holdings
Paragraph IV (Patent) Challenges for HALEON US HOLDINGS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 200 mg/38 mg | ➤ Subscribe | 2016-02-16 |
➤ Subscribe | Gum | 2 mg | ➤ Subscribe | 2013-01-22 |
➤ Subscribe | Capsules | 200 mg/30 mg | ➤ Subscribe | 2004-12-27 |
➤ Subscribe | Capsules | 60 mg | ➤ Subscribe | 2010-09-08 |
➤ Subscribe | Gum | 4 mg | ➤ Subscribe | 2013-01-22 |
International Patents for Haleon Us Holdings Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 1888042 | ⤷ Try a Trial |
Australia | 2011200912 | ⤷ Try a Trial |
Canada | 2559099 | ⤷ Try a Trial |
Japan | 4746031 | ⤷ Try a Trial |
China | 102076362 | ⤷ Try a Trial |
Norway | 336083 | ⤷ Try a Trial |
China | 100528257 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Haleon Us Holdings Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1305329 | 08C0014 | France | ⤷ Try a Trial | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
0428642 | 57/2007 | Austria | ⤷ Try a Trial | PRODUCT NAME: DOCOSANOL; NAT. REGISTRATION NO/DATE: 1-27014 20070518; FIRST REGISTRATION: SE 18517 20031114 |
0129748 | 98C0042 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ORLISTAT; REGISTRATION NO/DATE: EU/1/98/071/001 19980729 |
1519731 | 13C0067 | France | ⤷ Try a Trial | PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215 |
2506844 | 2018C/022 | Belgium | ⤷ Try a Trial | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
2506844 | 132018000000341 | Italy | ⤷ Try a Trial | PRODUCT NAME: UN PRODOTTO DI COMBINAZIONE FARMACEUTICA COMPRENDENTE UN SALE FARMACEUTICAMENTE ACCETTABILE DI UMECLIDINIO (AD ESEMPIO BROMURO DI UMECLIDINIO), VILANTEROLO O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE (AD ESEMPIO VILANTEROLO TRIFENATATO) E UN FUROATO(TRELEGY ELLIPTA - FLUTICASONE FUROATO/UMECLIDINIO/VILANTEROLO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1236, 20171117 |
1305329 | SPC/GB08/026 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080116; UK EU/1/07/434/002 20080116; UK EU/1/07/434/003 20080116 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.